A male and female gametocyte functional viability assay to identify biologically relevant malaria transmission-blocking drugs

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 12, 2014, Pages 7292-7304

  Ruecker, A ^a   Mathias, D K ^b   Straschil, U ^a   Churcher, T S ^a   Dinglasan, R R ^b   Leroy, D ^c   Sinden, R E ^a   Delves, M J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c Medicines for Malaria Venture   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; ARTESUNATE; CYCLOGUANIL; DIHYDROARTEMISININ; ENDOPEROXIDE; PYRIMETHAMINE; MOLECULAR LIBRARY;

ARTICLE; BIOASSAY; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GAMETOCYTE; GOLD STANDARD; HIGH THROUGHPUT SCREENING; IN VITRO STUDY; MALARIA FALCIPARUM; MALE; NONHUMAN; PARASITE DEVELOPMENT; PLASMODIUM FALCIPARUM STANDARD MEMBRANE FEEDING ASSAY; CELL SURVIVAL; DRUG EFFECTS; ERYTHROCYTE; GAMETOGENESIS; GROWTH, DEVELOPMENT AND AGING; HUMAN; LIFE CYCLE STAGE; MALARIA, FALCIPARUM; MOLECULAR LIBRARY; PARASITOLOGY; PHARMACOLOGY; PHYSIOLOGY; PLASMODIUM FALCIPARUM; TRANSMISSION;

ANTIMALARIALS; CELL SURVIVAL; ERYTHROCYTES; FEMALE; GAMETOGENESIS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; LIFE CYCLE STAGES; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; SMALL MOLECULE LIBRARIES;

EID: 84912554796     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03666-14     Document Type: Article

References (39)

1. Sinden RE. 2010. A biologist's perspective on malaria vaccine development. Hum. Vaccin. 6:3-11. http://dx.doi.org/10.4161/hv.6.1.9604.
2. Sinden RE. 1983. Sexual development of malarial parasites. Adv. Parasitol. 22:153-216. http://dx.doi.org/10.1016/S0065-308X(08)60462-5.
3. Alano P. 2007. Plasmodium falciparum gametocytes: still many secrets of a hidden life. Mol. Microbiol. 66:291-302. http://dx.doi.org/10.1111/j .1365-2958.2007.05904.x.
4. Billker O, Lindo V, Panico M, Etienne AE, Paxton T, Dell A, Rogers M, Sinden RE, Morris HR. 1998. Identification of xanthurenic acid as the putative inducer of malaria development in the mosquito. Nature 392: 289-292. http://dx.doi.org/10.1038/32667.
5. Toyé PJ, Sinden RE, Canning EU. 1977. The action of metabolic inhibitors on microgametogenesis in Plasmodium yoelii nigeriensis. Z. Parasitenkd. 53:133-141. http://dx.doi.org/10.1007/BF00380457.
6. Mair GR, Braks JA, Garver LS, Wiegant JC, Hall N, Dirks RW, Khan SM, Dimopoulos G, Janse CJ, Waters AP. 2006. Regulation of sexual development of Plasmodium by translational repression. Science 313: 667-669. http://dx.doi.org/10.1126/science.1125129.
7. van Dijk MR, Janse CJ, Thompson J, Waters AP, Braks JA, Dodemont HJ, Stunnenberg HG, van Gemert GJ, Sauerwein RW, Eling W. 2001. A central role for P48/45 in malaria parasite male gamete fertility. Cell 104: 153-164. http://dx.doi.org/10.1016/S0092-8674(01)00199-4.
8. Janse CJ, Mons B, Rouwenhorst RJ, Van der Klooster PF, Overdulve JP, Van der Kaay HJ. 1985. In vitro formation of ookinetes and functional maturity of Plasmodium berghei gametocytes. Parasitology 91:19-29. http://dx.doi.org/10.1017/S0031182000056481.
9. Vlachou D, Zimmermann T, Cantera R, Janse CJ, Waters AP, Kafatos FC. 2004. Real-time, in vivo analysis of malaria ookinete locomotion and mosquito midgut invasion. Cell. Microbiol. 6:671-685. http://dx.doi.org /10.1111/j.1462-5822.2004.00394.x.
10. Carter R, Ranford-Cartwright L, Alano P. 1993. The culture and preparation of gametocytes of Plasmodium falciparum for immunochemical, molecular, and mosquito infectivity studies. Methods Mol. Biol. 21:67-88
11. Burrows JN, Burlot E, Campo B, Cherbuin S, Jeanneret S, Leroy D, Spangenberg T, Waterson D, Wells TN, Willis P. 2013. Antimalarial drug discovery - the path towards eradication. Parasitology 141:128-139. http://dx.doi.org/10.1017/S0031182013000826.
12. Mulder B, Lensen T, Tchuinkam T, Roeffen W, Verhave JP, Boudin C, Sauerwein R. 1999. Plasmodium falciparum: membrane feeding assays and competition ELISAs for the measurement of transmission reduction in sera from Cameroon. Exp. Parasitol. 92:81-86. http://dx.doi.org/10 .1006/expr.1999.4398.
13. Burrows JN, Huijsduijnen RH, van Möhrle JJ, Oeuvray C, Wells TN. 2013. Designing the next generation of medicines for malaria control and eradication. Malar. J. 12:187. http://dx.doi.org/10.1186/1475-2875-12 -187.
14. Bousema T, Okell L, Shekalaghe S, Griffin JT, Omar S, Sawa P, Sutherland C, Sauerwein R, Ghani AC, Drakeley C. 2010. Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Malar. J. 9:136. http://dx.doi.org/10.1186 /1475-2875-9-136.
15. Duffy S, Avery VM. 2013. Identification of inhibitors of Plasmodium falciparum gametocyte development. Malar. J. 12:408. http://dx.doi.org /10.1186/1475-2875-12-408.
16. Tanaka TQ, Williamson KC. 2011. A malaria gametocytocidal assay using oxidoreduction indicator, alamarBlue. Mol. Biochem. Parasitol. 177:160-163. http://dx.doi.org/10.1016/j.molbiopara.2011.02.005.
17. D'Alessandro S, Silvestrini F, Dechering K, Corbett Y, Parapini S, Timmerman M, Galastri L, Basilico N, Sauerwein R, Alano P, Taramelli D. 2013. A Plasmodium falciparum screening assay for anti-gametocyte drugs based on parasite lactate dehydrogenase detection. J. Antimicrob. Chemother. 68:2048-2058. http://dx.doi.org/10.1093/jac/dkt165.
18. Lelièvre J, Almela MJ, Lozano S, Miguel C, Franco V, Leroy D, Herreros E. 2012. Activity of clinically relevant antimalarial drugs on Plasmodium falciparum mature gametocytes in an ATP bioluminescence "transmission blocking" assay. PLoS One 7:e35019. http://dx.doi.org/10.1371 /journal.pone.0035019.
19. Giao PT, Vries PJ, Binh TQ, Nam NV, Kager PA. 2005. Early diagnosis and treatment of uncomplicated malaria and patterns of health seeking in Vietnam. Trop. Med. Int. Health 10:919-925. http://dx.doi.org/10.1111/j .1365-3156.2005.01472.x.
20. Tangpukdee N, Krudsood S, Srivilairit S, Phophak N, Chonsawat P, Yanpanich W, Kano S, Wilairatana P. 2008. Gametocyte clearance in uncomplicated and severe Plasmodium falciparum malaria after artesunate- mefloquine treatment in Thailand. Korean J. Parasitol. 46:65-70. http://dx.doi.org/10.3347/kjp.2008.46.2.65.
21. Babiker HA, Gadalla AAH, Ranford-Cartwright LC. 2013. The role of asymptomatic P. falciparum parasitaemia in the evolution of antimalarial drug resistance in areas of seasonal transmission. Drug Resist. Updat. 16: 1-9. http://dx.doi.org/10.1016/j.drup.2013.02.001.
22. Smalley ME. 1977. Plasmodium falciparum gametocytes: the effect of chloroquine on their development. Trans. R. Soc. Trop. Med. Hyg. 71: 526-529. http://dx.doi.org/10.1016/0035-9203(77)90149-3.
23. Chutmongkonkul M, Maier WA, Seitz HM. 1992. A new model for testing gametocytocidal effects of some antimalarial drugs on Plasmodium falciparum in vitro. Ann. Trop. Med. Parasitol. 86:207-215.
24. Kumar N, Zheng H. 1990. Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu on Plasmodium falciparum. Parasitol. Res. 76:214-218. http://dx.doi.org/10.1007/BF00930817.
25. Delves MJ, Ramakrishnan C, Blagborough AM, Leroy D, Wells TNC, Sinden RE. 2012. A high-throughput assay for the identification of malarial transmission-blocking drugs and vaccines. Int. J. Parasitol. 42:999-1006. http://dx.doi.org/10.1016/j.ijpara.2012.08.009.
26. Spangenberg T, Burrows JN, Kowalczyk P, McDonald S, Wells TNC, Willis P. 2013. The open access Malaria Box: a drug discovery catalyst for neglected diseases. PLoS One 8:e62906. http://dx.doi.org/10.1371/journal .pone.0062906.
27. Alano P, Roca L, Smith D, Read D, Carter R, Day K. 1995. Plasmodium falciparum: parasites defective in early stages of gametocytogenesis. Exp. Parasitol. 81:227-235. http://dx.doi.org/10.1006/expr.1995.1112.
28. Delves MJ, Ruecker A, Straschil U, Lelièvre J, Marques S, López-Barragán MJ, Herreros E, Sinden RE. 2013. Male and female Plasmodium falciparum mature gametocytes show different responses to antimalarial drugs. Antimicrob. Agents Chemother. 57:3268-3274. http://dx.doi .org/10.1128/AAC.00325-13.
29. Zhang XD. 2011. Illustration of SSMD, z Score, SSMD∗, z∗ Score, and t Statistic for hit selection in RNAi high-throughput screens. J. Biomol. Screen. 16:775-785. http://dx.doi.org/10.1177/1087057111405851.
30. Churcher TS, Blagborough AM, Delves M, Ramakrishnan C, Kapulu MC, Williams AR, Biswas S, Da DF, Cohuet A, Sinden RE. 2012. Measuring the blockade of malaria transmission - an analysis of the standard membrane feeding assay. Int. J. Parasitol. 42:1037-1044. http://dx .doi.org/10.1016/j.ijpara.2012.09.002.
31. Robert V, Sokhna CS, Rogier C, Ariey F, Trape JF. 2003. Sex ratio of Plasmodium falciparum gametocytes in inhabitants of Dielmo, Senegal. Parasitology 127:1-8. http://dx.doi.org/10.1017/S0031182003003299.
32. Gbotosho GO, Sowunmi A, Happi CT, Okuboyejo TM. 2011. Plasmodium falciparum gametocyte carriage, sex ratios and asexual parasite rates in Nigerian children before and after a treatment protocol policy change instituting the use of artemisinin-based combination therapies. Mem. Inst. Oswaldo Cruz 106:685-690. http://dx.doi.org /10.1590/S0074-02762011000600007.
33. Lensen A, Bril A, van de Vegte M, van Gemert GJ, Eling W, Sauerwein R. 1999. Plasmodium falciparum: infectivity of cultured, synchronized gametocytes to mosquitoes. Exp. Parasitol. 91:101-103. http://dx.doi.org /10.1006/expr.1998.4354.
34. Ogwan'g RA, Mwangi JK, Githure J, Were JB, Roberts CR, Martin SK. 1993. Factors affecting exflagellation of in vitro-cultivated Plasmodium falciparum gametocytes. Am. J. Trop. Med. Hyg. 49:25-29.
35. Zhang X, Espeseth A, Chung N, Ferrer M. 2006. Evaluation of a novel metric for quality control in an RNA interference high throughput screening assay. Biocomp 2006:385-390.
36. Vial H, Taramelli D, Boulton IC, Ward SA, Doerig C, Chibale K. 2013. CRIMALDDI: platform technologies and novel anti-malarial drug targets. Malar. J. 12:396. http://dx.doi.org/10.1186/1475-2875-12-396.
37. Bowman JD, Merino EF, Brooks CF, Striepen B, Carlier PR, Cassera MB. 2014. Anti-apicoplast and gametocytocidal screening to identify the mechanisms of action of compounds within the Malaria Box. Antimicrob. Agents Chemother. 58:811-819. http://dx.doi.org/10.1128 /AAC.01500-13.
38. Sun W, Tanaka TQ, Magle CT, Huang W, Southall N, Huang R, Dehdashti SJ, McKew JC, Williamson KC, Zheng W. 2014. Chemical signatures and new drug targets for gametocytocidal drug development. Sci. Rep. 4:3743. http://dx.doi.org/10.1038/srep03743.
39. Ingram-Sieber K, Cowan N, Panic G, Vargas M, Mansour NR, Bickle QD, Wells TNC, Spangenberg T, Keiser J. 2014. Orally active antischistosomal early leads identified from the open access Malaria Box. PLoS Negl. Trop. Dis. 8:e2610. http://dx.doi.org/10.1371/journal.pntd .0002610.